CIK 0001533040
- Non-accelerated filer
- Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453215903
- Phone
- +1 508-767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- Open-market buys, last 90 days
- $86,928
- in 8 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$86,928. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-07-05 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −18,180 | $0.20 | $4K | 39,590,130 |
| 2013-07-03 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −50,000 | $0.19 | $10K | 39,758,310 |
| 2013-07-03 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −50,000 | $0.19 | $10K | 39,708,310 |
| 2013-07-02 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −9,249 | $0.20 | $2K | 39,838,310 |
| 2013-07-02 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −30,000 | $0.19 | $6K | 39,808,310 |
| 2013-07-01 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −50,000 | $0.20 | $10K | 39,897,559 |
| 2013-07-01 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −50,000 | $0.20 | $10K | 39,847,559 |
| 2013-06-28 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −46,874 | $0.20 | $9K | 39,947,559 |
| 2013-06-27 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −50,000 | $0.20 | $10K | 40,099,433 |
| 2013-06-27 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −60,000 | $0.19 | $12K | 40,039,433 |
| 2013-06-27 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −45,000 | $0.19 | $9K | 39,994,433 |
| 2013-06-26 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −50,000 | $0.20 | $10K | 40,174,933 |
| 2013-06-26 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −25,500 | $0.20 | $5K | 40,149,433 |
| 2013-06-25 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −50,000 | $0.19 | $10K | 40,224,933 |
| 2013-06-07 | Bitterman Robert J Director | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2013-06-07 | Brownlie Keith L Director | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2013-06-07 | Pavco Pamela Chief Development Officer | Grant or award · Stock Option (right to buy) | +2,000,000 | 2,000,000 | ||
| 2013-06-07 | CAUWENBERGH GEERT President & CEO | Grant or award · Stock Option (right to buy) | +4,000,000 | 4,000,000 | ||
| 2013-06-07 | Kontulis Caitlin Secretary & Controller | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2013-05-02 | Galena Biopharma, Inc. 10% owner | Sale | −253,000 | $0.19 | $48K | 32,393,095 |
Page 19 of 22 · 421 trades